APOPTOSIS OF SERUM-FREE C2.8 MOUSE EMBRYO HEPATOCYTIC CELLS CAUSED BY HEPATOCYTE GROWTH-FACTOR DEPRIVATION

被引:14
作者
REVOLTELLA, RP [1 ]
BORNEY, F [1 ]
DALCANTO, B [1 ]
DURSO, CM [1 ]
机构
[1] IND FARMACEUT SPA, SIGMA TAU, I-00040 POMEZIA, ITALY
关键词
APOPTOSIS; C2.8 HEPATOCYTIC CELLS; GROWTH FACTOR DEPRIVATION; HEPATOCYTE GROWTH FACTOR;
D O I
10.1007/BF00749971
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
C2.8 mouse embryo hepatocytic cells, acutely required exogenous hepatocyte growth factor (HGF) to survive and proliferate in serum-free Dulbecco's modified Eagle's medium supplemented with insulin, transferrin and Na-selenite. Greater than 90% of cultured C2.8 cells died within 48 hours from plating in the absence of HGF. Conversely, HGF prolonged maintenance of life and stimulated cell proliferation. Removal of HGF from the medium of cultures that had grown to confluency, also resulted in a rapid decreased cell survival. In the last circumstance, light microscopic observations revealed, with high frequency, morphological features characteristic of apoptosis. DNA within the affected cells underwent rapid fragmentation, revealed as a ladder of DNA fragments in multiples of about 200 base pairs. HGF prevented loss of cell viability, morphological damages and retarded DNA fragmentation in confluent C2.8 cells. Cycloheximide delayed cell death caused by HGF deprivation.
引用
收藏
页码:13 / 19
页数:7
相关论文
共 31 条
[1]   APOPTOSIS OF VASCULAR ENDOTHELIAL-CELLS BY FIBROBLAST GROWTH-FACTOR DEPRIVATION [J].
ARAKI, S ;
SHIMADA, Y ;
KAJI, K ;
HAYASHI, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 168 (03) :1194-1200
[2]  
BARONE E, 1992, J BIOL REGUL HOMEOST, V6, P35
[3]   CONTROLLED DEATH (APOPTOSIS) OF NORMAL AND PUTATIVE PRENEOPLASTIC CELLS IN RAT-LIVER FOLLOWING WITHDRAWAL OF TUMOR PROMOTERS [J].
BURSCH, W ;
LAUER, B ;
TIMMERMANNTROSIENER, I ;
BARTHEL, G ;
SCHUPPLER, J ;
SCHULTEHERMANN, R .
CARCINOGENESIS, 1984, 5 (04) :453-458
[4]  
COHEN JJ, 1984, J IMMUNOL, V132, P38
[5]  
COLUMBANO A, 1985, LAB INVEST, V52, P670
[6]  
DEMETRIOU AA, 1978, GASTROENTEROLOGY, V75, P959
[7]  
FRANCAVILLA A, 1987, CANCER RES, V47, P5600
[8]   BIOLOGICAL AND IMMUNOLOGICAL PROPERTIES OF HUMAN HEPATOCYTE GROWTH-FACTOR FROM PLASMA OF PATIENTS WITH FULMINANT HEPATIC-FAILURE [J].
GOHDA, E ;
YAMASAKI, T ;
TSUBOUCHI, H ;
KUROBE, M ;
SAKIYAMA, O ;
AOKI, H ;
NIIDANI, N ;
SHIN, S ;
HAYASHI, K ;
HASHIMOTO, S ;
DAIKUHARA, Y ;
YAMAMOTO, I .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1053 (01) :21-26
[9]   HUMAN HEPATOCYTE GROWTH-FACTOR IN PLASMA FROM PATIENTS WITH FULMINANT HEPATIC-FAILURE [J].
GOHDA, E ;
TSUBOUCHI, H ;
NAKAYAMA, H ;
HIRONO, S ;
TAKAHASHI, K ;
KOURA, M ;
HASHIMOTO, S ;
DAIKUHARA, Y .
EXPERIMENTAL CELL RESEARCH, 1986, 166 (01) :139-150
[10]   PURIFICATION AND PARTIAL CHARACTERIZATION OF HEPATOCYTE GROWTH-FACTOR FROM PLASMA OF A PATIENT WITH FULMINANT HEPATIC-FAILURE [J].
GOHDA, E ;
TSUBOUCHI, H ;
NAKAYAMA, H ;
HIRONO, S ;
SAKIYAMA, O ;
TAKAHASHI, K ;
MIYAZAKI, H ;
HASHIMOTO, S ;
DAIKUHARA, Y .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (02) :414-419